17 clinical scenarios were developed for which amyloid or tau PET may be considered. Gil D. Rabinovici, M.D., from the University of California San Francisco, and colleagues updated AUC for ...

Exercise may positively influence the interactions between brain cells in the hippocampus, a brain region involved in ...

Study suggests belly fat is a midlife indicator of Alzheimer’s disease Learn about the research on belly fat’s impact on brain health and strategies to reduce risk through lifestyle changes ...

Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...

New research uncovers how declining protein clearance mechanisms with age lead to Alzheimer’s, Parkinson’s, and other ...

Limbic-predominant age-related TDP-43 encephalopathy (LATE) is a recently characterized form of dementia that is distinct ...

Taking longer to get to deep sleep or REM sleep can disrupt memory consolidation and emotional processing, affecting overall ...

It reduces amyloid beta plaques in the brain, which is a defining pathophysiological feature of Alzheimer disease. The new approval allows patients to transition to the once every 4 weeks 10mg/kg ...

Revolutionary nasal spray offers hope by potentially delaying Alzheimer's progression through cutting-edge neurological ...

Jan. 15, 2025 — Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research points to a ...

insoluble tau aggregates in the central nervous system, which clump together to form neurofibrillary 'tangles', one of the hallmarks of Alzheimer's alongside the beta-amyloid plaques targeted by ...